Voyageur Pharmaceuticals (CVE:VM) Trading Down 31.3% – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM) was down 31.3% during mid-day trading on Wednesday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during mid-day trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Performance

The firm has a market capitalization of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32. The firm has a 50 day moving average price of C$0.10 and a 200-day moving average price of C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.